0001079973-25-001745
SEC filingNet loss decreased 4% QoQ and 9% YTD as R&D cuts offset G&A increases; cash position $34.9M sufficient through March 2027.
For the three months ended September 30, 2025, Lightwave Logic reported revenue of $29,166, compared to $22,916 in the same period last year, all from licensing and royalty revenue. Cost of sales was $0, down from $1,236. Research and development (R&D) expenses decreased 24% to $2.9M from $3.8M, driven by lower non-cash stock compensation, salary, prototype, and travel expenses. General and administrative (G&A) expenses increased 54% to $2.3M from $1.5M, primarily due to higher salary and stock compensation, partially offset by lower legal fees. Total operating expenses decreased 2% to $5.2M. Other income swung to $75,587 from a loss of $3,811, mainly due to a $175,849 decrease in loss on patent retirements, offset by higher commitment fees and lower interest income. Net loss improved to $5,100,559 from $5,300,913, a 4% decrease.
For the nine months ended September 30, 2025, revenue reached $77,688 (licensing) versus $72,688 in the prior period. Cost of sales was $5,491 versus $6,411. R&D expenses fell 32% to $8.6M from $12.8M, with similar drivers. G&A expenses rose 53% to $7.1M from $4.6M. Total operating expenses decreased 10% to $15.8M. Other income decreased 43% to $220,494 from $387,039, due to higher commitment fees and lower interest income, partially offset by lower loss on patent retirements. Net loss improved to $15,469,715 from $17,000,508, a 9% reduction.
The company operates as a single segment, focusing on electro-optic polymer materials and licensing. No segment-level disclosure is provided.
Management expects R&D expenses to increase as they accelerate development and commercialization efforts. They anticipate monthly expenditures of approximately $2.2M over the next 12 months. As of September 30, 2025, cash and cash equivalents were $34.9M, and management believes this is sufficient to fund operations through March 2027, with additional liquidity from the 2025 Lincoln Park Purchase Agreement ($26.8M remaining) and the Roth Capital ATM agreement ($12.2M remaining). The company has no debt.
Lightwave Logic ended Q3 2025 with $34.9M in cash and equivalents, up from $27.7M at year-end 2024, driven by equity issuances. No marketable securities or debt (excluding lease liabilities). Shareholders' equity stood at $41.2M. The company expects to incur ~$2.2M per month in expenditures, providing a cash runway through March 2027. A $30M purchase agreement (March 2025) with an institutional investor and an ATM facility provide additional liquidity; as of filing, $26.8M remained available under the purchase agreement and $12.2M under the ATM.
The only significant contractual obligation is the amended operating lease for its Colorado facility, with undiscounted future payments of $3.7M (present value $2.6M). The lease extends through 2033 with 3% annual escalations. No purchase commitments, supply agreements, or other long-term obligations exist. The company's sole commercial agreement (a four-year material supply and license) contributes minimal revenue ($77,688 in nine months) and generates a contract liability of $10,708.
The company does not pay dividends or repurchase shares. Capital spending totaled $953,184 in property and equipment during the nine months, primarily lab equipment. There is no debt issuance or repayment activity. Equity financing remains the primary capital source, with $14.4M raised via ATM and $3.0M from the institutional investor in the first nine months of 2025.
The company operates as a single reportable segment, with the CEO as CODM evaluating performance based on operating loss. For the nine months ended September 30, 2025, 100% of revenue was generated internationally (primarily from the license agreement). The company has one customer accounting for all revenue and accounts receivable. R&D expenses totaled $8.6M (55% of total costs), reflecting continued investment in electro-optic polymer development.
No cash flow statement data is available in the provided filing excerpt. The balance sheet shows an increase in cash of $7,274,106 from December 31, 2024 to September 30, 2025. The income statement reports a net loss of $15,469,715 for the same period. Without the cash flow statement, it is not possible to assess operating cash flow, investing activities, or financing activities. The company's net sales are minimal ($77,688), indicating it is still in a pre-revenue stage. The increase in cash likely stems from equity issuances, as the statements of stockholders' equity show significant proceeds from common stock sales and warrant exercises. Further analysis of cash flow quality is hindered by the absence of CFO, capex, and other cash flow components.